Capital Fund Management (CFM)’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Sell |
125,124
-150,350
| -55% | -$3.24M | 0.01% | 557 |
|
|
2025
Q1 | $4.58M | Sell |
275,474
-385,156
| -58% | -$6.4M | 0.01% | 374 |
|
|
2024
Q4 | $12.1M | Sell |
660,630
-123,399
| -16% | -$2.26M | 0.03% | 226 |
|
|
2024
Q3 | $12.1M | Sell |
784,029
-132,580
| -14% | -$2.04M | 0.03% | 195 |
|
|
2024
Q2 | $14.9M | Buy |
916,609
+221,062
| +32% | +$3.59M | 0.04% | 145 |
|
|
2024
Q1 | $12.9M | Buy |
695,547
+451,735
| +185% | +$8.35M | 0.04% | 185 |
|
|
2023
Q4 | $7.63M | Buy |
243,812
+68,120
| +39% | +$2.13M | 0.02% | 274 |
|
|
2023
Q3 | $3.66M | Sell |
175,692
-55,769
| -24% | -$1.16M | 0.01% | 363 |
|
|
2023
Q2 | $5.54M | Buy |
231,461
+70,616
| +44% | +$1.69M | 0.02% | 263 |
|
|
2023
Q1 | $3.03M | Sell |
160,845
-79,626
| -33% | -$1.5M | 0.01% | 305 |
|
|
2022
Q4 | $3.83M | Sell |
240,471
-22,655
| -9% | -$361K | 0.03% | 257 |
|
|
2022
Q3 | $4.3M | Buy |
263,126
+60,474
| +30% | +$989K | 0.03% | 214 |
|
|
2022
Q2 | $2.86M | Buy |
202,652
+122,533
| +153% | +$1.73M | 0.03% | 292 |
|
|
2022
Q1 | $1.94M | Buy |
80,119
+27,078
| +51% | +$656K | 0.02% | 374 |
|
|
2021
Q4 | $1.24M | Sell |
53,041
-8,305
| -14% | -$194K | 0.01% | 427 |
|
|
2021
Q3 | $1.02M | Buy |
61,346
+26,058
| +74% | +$433K | 0.01% | 421 |
|
|
2021
Q2 | $861K | Buy |
+35,288
| New | +$861K | 0.01% | 447 |
|
|
2020
Q4 | – | Sell |
-13,550
| Closed | -$559K | – | 541 |
|
|
2020
Q3 | $559K | Sell |
13,550
-3,477
| -20% | -$143K | 0.01% | 468 |
|
|
2020
Q2 | $825K | Buy |
+17,027
| New | +$825K | 0.01% | 350 |
|
|
2020
Q1 | – | Sell |
-8,493
| Closed | -$363K | – | 828 |
|
|
2019
Q4 | $363K | Sell |
8,493
-437
| -5% | -$18.7K | ﹤0.01% | 723 |
|
|
2019
Q3 | $321K | Buy |
+8,930
| New | +$321K | ﹤0.01% | 623 |
|